文献速递腹部泌尿生殖MR

验证感兴趣区测量用于客观评估MRI上肾脏病灶增强

Validation of Region of Interest Measurements for the Objective Assessment of Post-Contrast Enhancement of Renal Lesions on MRI.
PubMed 文献 · Br J Radiol · 2019-08-07

本研究纳入2015年1月至2017年12月间104例已知肾脏肿块并后续活检或肾切除的患者,由两名腹部影像 fellow 独立测量病灶、正常肾实质、同侧腰大肌和外部空气在增强前后的感兴趣区均值。病理证实的肾细胞癌增强前后感兴趣区均值最小百分比变化为23%,病理证实的肾囊肿最大百分比变化为13%,两名读者间观察者一致性极好(组内相关系数0.81)。

要点

  • 病理证实肾细胞癌增强前后感兴趣区均值最小百分比变化为23%,可作为真性增强的最低阈值。
  • 病理证实肾囊肿增强前后感兴趣区均值最大百分比变化为13%,有助于与强化病灶鉴别。
  • 感兴趣区测量百分比变化(信号强度指数)可补充减影图像,在减影图像受运动伪影影响时仍可辅助判断。

核心结论

  • 感兴趣区均值百分比变化(信号强度指数)可作为客观评估肾脏肿块真性增强的有用工具,并可补充减影图像。
  • 本研究中增强的最低阈值为23%。

研究设计与样本

  • 本研究为验证性研究,纳入2015年1月至2017年12月间因已知肾脏肿块行对比增强肾脏MRI、且后续有活检或部分/根治性肾切除术的患者。
  • 共纳入104例患者(平均年龄65岁;男58例,女46例),其中74例(71%)诊断为肾细胞癌。
  • 由两名腹部影像 fellow 独立测量肾脏肿块、正常肾实质、同侧腰大肌和外部空气在增强前及增强后序列上的感兴趣区均值,并计算绝对变化和百分比变化。
  • 两名读者对病理结果设盲。

关键影像表现/征象

  • 病理证实的肾细胞癌增强前后感兴趣区均值最小百分比变化为23%(范围23%-437%,均值143%),代表相对增强,称为信号强度指数。
  • 正常肾实质增强前后感兴趣区均值百分比变化范围为32%-317%。
  • 病理证实的肾囊肿增强前后感兴趣区均值最大百分比变化为13%(范围-5%-13%,均值3.5%)。

诊断标准与关键数值

  • 病理证实肾细胞癌增强前后感兴趣区均值最小百分比变化为23%,作为真性增强的最低阈值。
  • 病理证实肾囊肿增强前后感兴趣区均值最大百分比变化为13%。
  • 感兴趣区测量百分比变化(信号强度指数)在两名读者间的组内相关系数为0.81,提示观察者一致性极好。

临床应用与阅片要点

  • 感兴趣区测量增强前后百分比变化(信号强度指数)可作为客观评估肾脏肿块真性增强的补充工具,与减影图像联合使用。
  • 在减影图像受运动伪影影响而质量下降时,感兴趣区测量百分比变化可能有助于检测和诊断肾脏病灶。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The aim of this study was to validate the use of region of interest (ROI) measurements in MRI to objectively assess for enhancement in suspected solid renal masses and to determine a minimum threshold value for true enhancement.

METHODS: Contrast-enhanced renal MRI studies performed between January 2015 and December 2017 for patients with a known renal mass who had subsequent biopsy, or partial/radical nephrectomy were included. Two body imaging fellows independently measured the mean ROI values of renal masses, normal renal parenchyma, the ipsilateral psoas muscle and external air on the pre- and post-contrast sequences. The absolute and percentage changes in the mean ROI values were calculated. The readers were blinded to the pathology results.

RESULTS: 104 patients were included in this study (mean age of 65 years; 58 males and 46 females). 74 patients (71%) had a diagnosis of renal cell carcinoma (RCC). Pathology showed clear-cell RCC in 55%, papillary RCC in 22%, and other RCC subtypes in 23%. There were 30 non-RCC renal lesions (29%), including oncocytoma, renal papillary adenoma, and renal metastasis.The minimum percentage change in ROI values in the pre- versus post-contrast images for all pathology-proven RCCs was 23% (range: 23-437%, mean: 143%); this represents relative enhancement and was referred to as the Signal Intensity Index (SII). The percentage change for normal renal parenchyma ranged from 32-317%. The maximum percentage change in ROI values for pathology proven renal cysts was 13% (range: -5-13%, mean: 3.5%). There was excellent inter observer agreement between the two readers [Intra-class correlation coefficient (r) 0.81].

CONCLUSION: The percentage change in ROI values (SII) can be a helpful tool in the objective assessment of true enhancement of renal masses and can supplement subtraction images. The minimum threshold for enhancement in our study was 23%.

ADVANCES IN KNOWLEDGE: Enhancement of a renal lesion can be determined using the objective tool of ROI measurements in the pre- and post-contrast MR images with a percentage change of 20% or above indicating enhancement. This is an additional objective tool, which in conjunction with the subtraction images may improve detection and appropriate diagnosis of renal lesions. It could also be helpful in cases where the subtraction images are degraded by motion artefact.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Al Salmi IS, Halperin J, Al-Douri F, et al. Validation of Region of Interest Measurements for the Objective Assessment of Post-Contrast Enhancement of Renal Lesions on MRI. Br J Radiol. 2019. PMID: 31365281. doi:10.1259/bjr.20190507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。